{"count": 23, "results": [{"_id": "34122067", "pmid": 34122067, "pmcid": "PMC8191634", "title": "Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice", "journal": "Front Pharmacol", "authors": ["Liu Z", "Liao W", "Zhang Z", "Sun R", "Luo Y", "Chen Q", "Li X", "Lu R", "Ying Y"], "date": "2021-05-21T00:00:00Z", "doi": "10.3389/fphar.2021.640347", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "640347", "score": 50275.805, "text_hl": "Changes in bacterial community composition and diversity-related to @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@IBD@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment were assessed by high-throughput metagenomic sequencing analysis.", "citations": {"NLM": "Liu Z, Liao W, Zhang Z, Sun R, Luo Y, Chen Q, Li X, Lu R, Ying Y. Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice Front Pharmacol. 2021;12():640347. PMID: 34122067", "BibTeX": "@article{34122067, title={Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice}, author={Liu Z and Liao W and Zhang Z and Sun R and Luo Y and Chen Q and Li X and Lu R and Ying Y}, journal={Front Pharmacol}, volume={12}, pages={640347}}"}}, {"_id": "36099786", "pmid": 36099786, "title": "Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic.", "journal": "Int Immunopharmacol", "authors": ["Wanchaitanawong W", "Thinrungroj N", "Chattipakorn SC", "Chattipakorn N", "Shinlapawittayatorn K"], "date": "2022-11-01T00:00:00Z", "doi": "10.1016/j.intimp.2022.109230", "meta_date_publication": "2022 Nov", "meta_volume": "112", "meta_issue": "", "meta_pages": "109230", "score": 50263.297, "text_hl": "Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potential treatment for @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@: Evidence from cell to the clinic.", "citations": {"NLM": "Wanchaitanawong W, Thinrungroj N, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K. Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic. Int Immunopharmacol. 2022 Nov;112():109230. PMID: 36099786", "BibTeX": "@article{36099786, title={Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic.}, author={Wanchaitanawong W and Thinrungroj N and Chattipakorn SC and Chattipakorn N and Shinlapawittayatorn K}, journal={Int Immunopharmacol}, volume={112}, pages={109230}}"}}, {"_id": "35419709", "pmid": 35419709, "pmcid": "PMC9007580", "title": "The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases", "journal": "Inflammopharmacology", "authors": ["Hasanvand A"], "date": "2022-06-01T00:00:00Z", "doi": "10.1007/s10787-022-00980-6", "meta_date_publication": "2022 Jun", "meta_volume": "30", "meta_issue": "3", "meta_pages": "775-788", "score": 50260.33, "text_hl": "Several studies have indicated that apart from its significant role in the reduction of blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ level, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activates the @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ enzyme that in turn has various efficient impacts on the regulation of various processes, including controlling @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ conditions, altering the differentiation pathway of immune and non-immune cell pathways, and the amelioration of various @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancers@@@, @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@liver diseases@@@, @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@ (@<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@IBD@@@), @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney diseases@@@, @DISEASE_Neurologic_Manifestations @DISEASE_MESH:D009461 @@@neurological disorders@@@, etc. ", "citations": {"NLM": "Hasanvand A. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases Inflammopharmacology. 2022 Jun;30(3):775-788. PMID: 35419709", "BibTeX": "@article{35419709, title={The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases}, author={Hasanvand A}, journal={Inflammopharmacology}, volume={30}, number={3}, pages={775-788}}"}}, {"_id": "39710207", "pmid": 39710207, "title": "The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules.", "journal": "J Control Release", "authors": ["Kim EJ", "Jeong HS", "Park JY", "Je JY", "Choi CH", "Lee SJ"], "date": "2024-12-24T00:00:00Z", "doi": "10.1016/j.jconrel.2024.12.041", "meta_date_publication": "2024 Dec 24", "meta_volume": "378", "meta_issue": "", "meta_pages": "490-502", "score": 50256.152, "text_hl": "The @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@ and gut microbiome are restored by employing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-loaded @CHEMICAL_Alginates @CHEMICAL_MESH:D000464 @@@alginate@@@-shelled microcapsules.", "citations": {"NLM": "Kim EJ, Jeong HS, Park JY, Je JY, Choi CH, Lee SJ. The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules. J Control Release. 2024 Dec 24;378():490-502. PMID: 39710207", "BibTeX": "@article{39710207, title={The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules.}, author={Kim EJ and Jeong HS and Park JY and Je JY and Choi CH and Lee SJ}, journal={J Control Release}, volume={378}, pages={490-502}}"}}, {"_id": "35780256", "pmid": 35780256, "title": "Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study.", "journal": "J Gastroenterol", "authors": ["Allin KH", "Jensen CB", "Jacobsen RK", "Jess T"], "date": "2022-10-01T00:00:00Z", "doi": "10.1007/s00535-022-01896-2", "meta_date_publication": "2022 Oct", "meta_volume": "57", "meta_issue": "10", "meta_pages": "761-769", "score": 50255.707, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use is not associated with reduced risk of older onset @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@: a Danish nationwide population-based study.", "citations": {"NLM": "Allin KH, Jensen CB, Jacobsen RK, Jess T. Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study. J Gastroenterol. 2022 Oct;57(10):761-769. PMID: 35780256", "BibTeX": "@article{35780256, title={Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study.}, author={Allin KH and Jensen CB and Jacobsen RK and Jess T}, journal={J Gastroenterol}, volume={57}, number={10}, pages={761-769}}"}}, {"_id": "38006803", "pmid": 38006803, "title": "Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.", "journal": "Biochem Biophys Res Commun", "authors": ["Hahn S", "Kim G", "Jin SM", "Kim JH"], "date": "2023-11-22T00:00:00Z", "doi": "10.1016/j.bbrc.2023.149291", "meta_date_publication": "2023 Nov 22", "meta_volume": "690", "meta_issue": "", "meta_pages": "149291", "score": 50255.145, "text_hl": "Thus, here, we used three-dimensional structure intestinal organoids to investigate effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the in vitro @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@IBD@@@ condition. ", "citations": {"NLM": "Hahn S, Kim G, Jin SM, Kim JH. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model. Biochem Biophys Res Commun. 2023 Nov 22;690():149291. PMID: 38006803", "BibTeX": "@article{38006803, title={Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model.}, author={Hahn S and Kim G and Jin SM and Kim JH}, journal={Biochem Biophys Res Commun}, volume={690}, pages={149291}}"}}, {"_id": "32604412", "pmid": 32604412, "title": "Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.", "journal": "J Crohns Colitis", "authors": ["Tseng CH"], "date": "2021-01-13T00:00:00Z", "doi": "10.1093/ecco-jcc/jjaa136", "meta_date_publication": "2021 Jan 13", "meta_volume": "15", "meta_issue": "1", "meta_pages": "64-73", "score": 50253.99, "text_hl": "AIM: Our aim was to compare the risk of developing @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@ [@<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@IBD@@@] between ever users and never users of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Tseng CH. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus. J Crohns Colitis. 2021 Jan 13;15(1):64-73. PMID: 32604412", "BibTeX": "@article{32604412, title={Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.}, author={Tseng CH}, journal={J Crohns Colitis}, volume={15}, number={1}, pages={64-73}}"}}, {"_id": "35064693", "pmid": 35064693, "title": "Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation.", "journal": "FASEB J", "authors": ["Takahara M", "Takaki A", "Hiraoka S", "Takei K", "Yasutomi E", "Igawa S", "Yamamoto S", "Oka S", "Ohmori M", "Yamasaki Y", "Inokuchi T", "Kinugasa H", "Harada K", "Udono H", "Okada H"], "date": "2022-02-01T00:00:00Z", "doi": "10.1096/fj.202100831RR", "meta_date_publication": "2022 Feb", "meta_volume": "36", "meta_issue": "2", "meta_pages": "e22139", "score": 50252.527, "text_hl": "Furthermore, we examined the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on an in vivo @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@IBD@@@ model. ", "citations": {"NLM": "Takahara M, Takaki A, Hiraoka S, Takei K, Yasutomi E, Igawa S, Yamamoto S, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Udono H, Okada H. Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation. FASEB J. 2022 Feb;36(2):e22139. PMID: 35064693", "BibTeX": "@article{35064693, title={Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation.}, author={Takahara M and Takaki A and Hiraoka S and Takei K and Yasutomi E and Igawa S and Yamamoto S and Oka S and Ohmori M and Yamasaki Y and Inokuchi T and Kinugasa H and Harada K and Udono H and Okada H}, journal={FASEB J}, volume={36}, number={2}, pages={e22139}}"}}, {"_id": "40601368", "pmid": 40601368, "title": "Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, Population-Based cohort study.", "journal": "J Natl Cancer Inst", "authors": ["Huang YJ", "Lin JA", "Chen WM", "Shia BC", "Wu SY"], "date": "2025-07-02T00:00:00Z", "doi": "10.1093/jnci/djaf165", "meta_date_publication": "2025 Jul 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.004, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use and risk of @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@inflammatory bowel disease@@@: a nationwide, Population-Based cohort study.", "citations": {"NLM": "Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY. Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, Population-Based cohort study. J Natl Cancer Inst. 2025 Jul 2;():. PMID: 40601368", "BibTeX": "@article{40601368, title={Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, Population-Based cohort study.}, author={Huang YJ and Lin JA and Chen WM and Shia BC and Wu SY}, journal={J Natl Cancer Inst}}"}}, {"_id": "34927008", "pmid": 34927008, "title": "Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?", "journal": "ACS Pharmacol Transl Sci", "authors": ["Ala M", "Ala M"], "date": "2021-11-01T00:00:00Z", "doi": "10.1021/acsptsci.1c00167", "meta_date_publication": "2021 Dec 10", "meta_volume": "4", "meta_issue": "6", "meta_pages": "1747-1770", "score": 50248.71, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for Cardiovascular Protection, @<m>DISEASE_Inflammatory_Bowel_Diseases</m> @DISEASE_MESH:D015212 @@@Inflammatory Bowel Disease@@@, @DISEASE_Osteoporosis @DISEASE_MESH:D010024 @@@Osteoporosis@@@, @DISEASE_Periodontitis @DISEASE_MESH:D010518 @@@Periodontitis@@@, @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@Polycystic Ovarian Syndrome@@@, @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@Neurodegeneration@@@, @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Cancer@@@, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@Inflammation@@@ and Senescence: What Is Next?", "citations": {"NLM": "Ala M, Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? ACS Pharmacol Transl Sci. 2021 Dec 10;4(6):1747-1770. PMID: 34927008", "BibTeX": "@article{34927008, title={Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?}, author={Ala M and Ala M}, journal={ACS Pharmacol Transl Sci}, volume={4}, number={6}, pages={1747-1770}}"}}]}